GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Krka d.d. (XLJU:KRKG) » Definitions » Deferred Policy Acquisition Costs

Krka d.d. (XLJU:KRKG) Deferred Policy Acquisition Costs


View and export this data going back to 1997. Start your Free Trial

What is Krka d.d. Deferred Policy Acquisition Costs?

Deferred Policy Acquisition Costs only applies to banks and insurance companies.


Krka d.d. (XLJU:KRKG) Business Description

Industry
Traded in Other Exchanges
Address
Smarjeska Cesta 6, Novo Mesto, SVN, 8501
Krka d.d. engages in the development, production, marketing, and sales of human health products (prescription pharmaceuticals and non-prescription products), animal health products, health resort, and tourist services. The company products in Prescription pharmaceuticals include Cardiovascular diseases, Infections, Oncology; Non-prescription products include Cold and cough products, nasal products, vitamin and minerals, hair care products; and Animal health products include Antimicrobials, Disinfectants, among others. It operates across the European Union, South-East Europe, East Europe region, and Others. The company derives a majority of revenue from the European Union.